SCHEMBL9518969

SCHEMBL9518969

COC(=O)C(O)(O)CCCCCc1c(-c2ccc(F)cc2)cn(C(C)C)c1C

nearest known ligand 0.52

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 5/20 0.52
GCGR P47871 5/20 0.33
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
MAP4K4 O95819 1/20 0.32
TNIK Q9UKE5 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32
CACNA1G O43497 1/20 0.31
ABCB1 P08183 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9518482 0.81 HMGCR (0.49) HMGCRSLC6A4SLC6A3PTGDR2CACNA1G
SCHEMBL9518809 0.79 HMGCR (0.43) HMGCRSLC6A4SLC6A3ABCB1
SCHEMBL9025275 0.74 GCGR (0.34) GCGR
SCHEMBL9750906 0.73 HMGCR (0.78) HMGCR
SCHEMBL9518755 0.70 SLC6A4 (0.47) HMGCRGCGRSLC6A4SLC6A3ABCB1
SCHEMBL9750822 0.67 HMGCR (1.00) HMGCR
SCHEMBL9518613 0.65 HMGCR (0.54) HMGCRSLC6A4SLC6A3
SCHEMBL5731755 0.64 KDM4E (0.48) HMGCRGCGR
SCHEMBL9023815 0.63 GCGR (0.31) HMGCRGCGR
SCHEMBL9750845 0.62 HMGCR (0.56) HMGCRPTGDR2ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0300249-B1 7-[1H-pyrrol-3-yl]-substituted 3,5-dihydroxy-heptane acids, their corresponding delta-lactones and salts, processes for their manufacture, their use as medicines, pharmaceutical preparations and intermediates HOECHST AKTIENGESELLSCHAFT (DE) 1993-02-03 EP disclosed
EP-0300249-A1 7-[1H-pyrrol-3-yl]-substituted 3,5-dihydroxy-heptane acids, their corresponding delta-lactones and salts, processes for their manufacture, their use as medicines, pharmaceutical preparations and intermediates HOECHST AKTIENGESELLSCHAFT (DE) 1989-01-25 EP disclosed